Paying users zone. Data is covered by hidden.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal
Verified by Visa MasterCard SecureCode American Express SafeKey
Microsoft Excel LibreOffice Calc

Celgene Corp. (CELG)


Common-Size Statement of Financial Position, Liabilities and Stockholders’ Equity

Difficulty: Beginner

Celgene Corp., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders’ Equity

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Short-term borrowings and current portion of long-term debt hidden hidden hidden hidden hidden
Accounts payable hidden hidden hidden hidden hidden
Rebates, distributor chargebacks and distributor services hidden hidden hidden hidden hidden
Compensation hidden hidden hidden hidden hidden
Clinical trial costs and grants hidden hidden hidden hidden hidden
Litigation-related loss contingency hidden hidden hidden hidden hidden
Interest hidden hidden hidden hidden hidden
Sales, use, value added, and other taxes hidden hidden hidden hidden hidden
Milestones payable hidden hidden hidden hidden hidden
Success payment liability hidden hidden hidden hidden hidden
Short-term contingent consideration and success payments hidden hidden hidden hidden hidden
Royalties, license fees and collaboration agreements hidden hidden hidden hidden hidden
Deferred tax liability hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Accrued expenses and other current liabilities hidden hidden hidden hidden hidden
Income taxes payable hidden hidden hidden hidden hidden
Current portion of deferred revenue hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Deferred revenue, net of current portion hidden hidden hidden hidden hidden
Income taxes payable hidden hidden hidden hidden hidden
Deferred income tax liabilities hidden hidden hidden hidden hidden
Other non-current tax liabilities hidden hidden hidden hidden hidden
Contingent consideration hidden hidden hidden hidden hidden
Deferred compensation and long-term incentives hidden hidden hidden hidden hidden
Contingent value rights hidden hidden hidden hidden hidden
Derivative contracts hidden hidden hidden hidden hidden
Other hidden hidden hidden hidden hidden
Other non-current liabilities hidden hidden hidden hidden hidden
Long-term debt, net of discount, excluding current portion hidden hidden hidden hidden hidden
Non-current liabilities hidden hidden hidden hidden hidden
Total liabilities hidden hidden hidden hidden hidden
Preferred stock, $.01 par value per share; none outstanding hidden hidden hidden hidden hidden
Common stock, $.01 par value per share hidden hidden hidden hidden hidden
Common stock in treasury, at cost hidden hidden hidden hidden hidden
Additional paid-in capital hidden hidden hidden hidden hidden
Retained earnings hidden hidden hidden hidden hidden
Accumulated other comprehensive income (loss) hidden hidden hidden hidden hidden
Stockholders’ equity hidden hidden hidden hidden hidden
Total liabilities and stockholders’ equity hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-07), 10-K (filing date: 2017-02-10), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-20).

Item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Celgene Corp.’s current liabilities as a percentage of total liabilities and stockholders’ equity declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Non-current liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Celgene Corp.’s non-current liabilities as a percentage of total liabilities and stockholders’ equity increased from 2016 to 2017 and from 2017 to 2018.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Celgene Corp.’s total liabilities as a percentage of total liabilities and stockholders’ equity increased from 2016 to 2017 and from 2017 to 2018.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Celgene Corp.’s stockholders’ equity as a percentage of total liabilities and stockholders’ equity declined from 2016 to 2017 and from 2017 to 2018.